Vimarsana
Biggest News Aggregation in the World

Diagnostics Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Platform Today - Breaking & Trending Today

Rosecliff Acquisition I : Business Combination Agreement - Form 8-K - Vimarsana News

Rosecliff Acquisition I : Business Combination Agreement - Form 8-K

April 11, 2023 Spectral MD Holdings, Ltd. ... | April 11, 2023

Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I - Vimarsana News

Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I

Spectral MD is an Artificial Intelligence company focused on predictive medical diagnostics. The Company’s FDA Breakthrough Designated DeepView AI Wound Diagnostics platform uses proprietary... | April 11, 2023

Rosecliff Acquisition Corp. I: Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I - Vimarsana News

Rosecliff Acquisition Corp. I: Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I

Spectral MD is an Artificial Intelligence (AI) company focused on predictive medical diagnostics. The Company's FDA Breakthrough Designated DeepView AI Wound Diagnostics platform ("DeepView") uses

RNA Disease Diagnostics Expands Board of Directors - Vimarsana News

RNA Disease Diagnostics Expands Board of Directors

- Lead Co-Inventor and Licensor of RNADD’s Molecular Diagnostics Platform to Help Guide its Commercialization - - Company’s President Expands Role - ...

Harvard Wyss Institute's eRapid sensor technology licensed - Vimarsana News

Harvard Wyss Institute's eRapid sensor technology licensed

The low-cost multiplexed electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics to be put into the hands of...